The widespread availability of naloxone, which reverses overdoses, has radically changed the culture of opioid use on the streets, giving drug users a sense of security and inducing them to seek out the more powerful high of the synthetic opioid fentanyl.
It’s never easy to tell a patient about a terminal illness, but a longtime doctor whose own diagnosis was botched says physicians must do better.
Supporters of the rule say it would strengthen health care professionals’ freedom of conscience, but opponents say it “empowers bad actors to be bad actors.”
An unexpected hospital bill can bust the family budget. That leaves lots of people with bills they can’t pay. Turns out, that’s a crisis for hospitals too, and some are getting creative about collecting debt.
In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.
Boomers are aging reluctantly but, for the most part, gracefully. Many even have found the secret to shaving a decade or more off their physical age.
Across the nation, public health departments are redirecting scarce resources to try to control the spread of measles. Their success relies on shoe-leather detective work that is one of the great untold costs of the measles resurgence.
Some Veterans Affairs hospitals around the country use writers to record patients’ life stories, then place a short biography in each vet’s medical record. The My Life, My Story program gives clinicians another way to get to know their patients.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
The scientific use of tissue from aborted fetuses has frequently been a hot point of contention between anti-abortion forces and researchers. It heats up again as federal officials announced this week they were ending NIH research using the tissue.
